Evaluation of cfDNA as an early detection assay for dense tissue breast cancer

A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. Recently, investigations of cfDNA as a reliable early detection bioassay have presented a powerful o...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbirou, Mouadh, Miller, Amanda A., Gafni, Erik, Mezlini, Amel, Zidi, Asma, Boley, Nathan, Tonellato, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120463/
https://www.ncbi.nlm.nih.gov/pubmed/35589867
http://dx.doi.org/10.1038/s41598-022-12457-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120463/
https://www.ncbi.nlm.nih.gov/pubmed/35589867
http://dx.doi.org/10.1038/s41598-022-12457-1

Ejemplares similares